Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04898283 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint revisedv7 Show 5 more changesShow less
    • Study sites: 24 to 27
    • Eligibility criteria expanded, about 23 words
    • Secondary endpoints: 8 to 17
    • Study description expanded, about 43 words
    • Publications: 1 to 2
  2. Primary completion date: Dec 2023 to Oct 2026v6 Show 4 more changesShow less
    • Study sites: 18 to 24
    • Study completion date: Apr 2024 to Oct 2026
    • Eligibility criteria revised
    • Study description revised
  3. Primary completion date: Dec 2022 to Dec 2023v5 Show 4 more changesShow less
    • Study sites: 14 to 18
    • Study completion date: Apr 2023 to Apr 2024
    • Eligibility criteria expanded, about 48 words
    • Secondary endpoints: details revised at 2 of 8 entries
  4. Study sites: 12 to 14v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised at 12 of 12 sites
    v3
  6. Secondary endpoints: 7 to 8v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Inmunotek S.L.
10 trials monitored
See all monitored trials
Asthma
956 trials monitored
See 34 trials at risk
A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma Sensitized to cupressaceae and grasses.
Trial Details
NCT Number NCT04898283
Lead Sponsor Inmunotek S.L.
Conditions
(from sponsor)		 Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
Related terms Asthma, Hypersensitivity, Rhinitis, Allergic
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov